Search Results for gene therapy
Uh oh. Bubble Talk is Back in Biotech
Recap - Healthcare stocks were routed early this week, falling 10% (based on the NASDAQ Biotech Index) before a bounce from mid-week into Friday. The similarities to … Continue Reading
Read now
OHRP Drops on Latest Clinical Trial Results
Insights - Top-line results from Ohr Pharmaceuticals’ (OHRP) phase II IMPACT study, testing its squalamine eyedrops in age-related macular degeneration (wet-AMD), had a crushing effect on the stock Friday. … Continue Reading
Read now
Esperion‘s Oral Cholesterol Drug Passes Latest Hurdle
Insights - Esperion Therapeutics, Inc. (ESPR) on released positive Phase 2b results for ETC-1002, its novel, oral cholesterol lowering therapy.
Read now
New, Competing Cholesterol Drugs Improving Outcomes for Patients
Insights - The big news this weekend out of the American College of Cardiology's annual scientific session was the comparison of long-term outcomes for two new (and competing) drugs targeting cholesterol,
Read now
SAGE and Marinus: Can’t Look at One Without the Other
Research - SAGE Therapeutics (SAGE) and Marinus Pharmaceuticals (MRNS)are innovators in a class of molecules known as neurosteroids and both target epilepsy initially.
Premium
What Investors Should Know About Proposed (& Drastic) Changes to the FDA
Insights - A draft of the 21st Century Cures Act carries serious implications for biopharma. Longer exclusivity, a faster approval process, and even the chance to SELL some exclusivity for certain products.
Read now